Total
0
Shares
Source: Field Trip Health
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Field Trip Health (FTRP) will release financial results for the fiscal second quarter after market close on Monday, November 15, 2021
  • The company will conduct a conference call and webcast to discuss its results on Tuesday, November 16 at 8:30 am ET
  • A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health Investor Relations website
  • Field Trip is a global leader in the development and delivery of psychedelic therapies
  • Field Trip Health Ltd. (FTRP) opened trading at C$6.60 per share

Field Trip Health (FTRP) will release financial results for the fiscal second quarter ended September 30, 2021, after market close on November 15.

The company will conduct a conference call and webcast to discuss its results on Tuesday, November 16 at 8:30 am ET. To access the call, please dial 1-877-407-9716 (within the U.S.) or 1-201-493-6779 (outside the U.S.) and provide conference ID 13724604.

A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health Investor Relations website here.

For those unable to attend the live call, a telephonic replay will be available until 11:59 pm ET on Tuesday, November 30, 2021. To access the replay of the call dial 1-844-512-2921 (within the U.S.) or 1-412-317-6671 (outside the U.S.) and provide conference ID 13724604.

An archived copy of the webcast will be available on the Events and Presentations section of the Field Trip Health Investor Relations website after the conclusion of the call.

Field Trip is a global leader in the development and delivery of psychedelic therapies.

Field Trip Health Ltd. (FTRP) opened trading at C$6.60 per share.

More From The Market Herald
Theratechnologies - CEO, Paul Lévesque.

" Theratechnologies (TSX:TH) receives 2021 ADRIQ Innovation Award

Theratechnologies (TH) has taken home a 2021 ADRIQ Innovation Award in the Life Sciences category.

" Elixxer Ltd. (TSXV:ELXR) welcomes new director

Elixxer (ELXR) is pleased to welcome Mr. Jeremy Green to the corporation’s board of directors. 

" Psyence Group (CSE:PSYG) to speak at the annual Global Wellness Summit

Psyence Group (PSYG) will break new ground as the first psychedelic company invited to speak at the 15th Annual Global Wellness Summit.

" Leveljump Healthcare Corp. (TSXV:JUMP) announces investment in Real Time Medical

Leveljump Healthcare (JUMP) has agreed to acquire a 14.6 per cent equity interest in Real Time Medical.